Naoaki Sakamoto Selected Research

11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acid

10/2021

Extraction and measurement of urinary tetranor-PGDM in disposable diapers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoaki Sakamoto Research Topics

Disease

3	Huntington Disease (Huntington's Disease) 07/2006 - 10/2003
2	Food Hypersensitivity (Food Allergy) 01/2023 - 10/2021
1	Dyspnea (Shortness of Breath) 01/2024
1	Allergic Rhinitis 01/2024
1	Deafness (Deaf Mutism) 12/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023
1	Colitis 01/2023
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2015
1	Gaucher Disease (Gaucher's Disease) 04/2015
1	Hypersensitivity (Allergy) 01/2012
1	Demyelinating Diseases (Demyelinating Disease) 10/2010
1	Heart Failure 10/2010
1	Atrophy 10/2009

Drug/Important Bio-Agent (IBA)

1	15-hydroxyeicosatrienoic acidIBA 01/2024
1	LipidsIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	AzoxymethaneIBA 01/2023
1	ProstaglandinsIBA 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	OvalbuminIBA 01/2023
1	prostaglandin D2 receptorIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	11,15- dioxo- 9- hydroxy- 2,3,4,5- tetranorprostan- 1,20- dioic acidIBA 10/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 04/2015
1	alpha-SynucleinIBA 04/2015
1	B-Form DNA (B-DNA)IBA 01/2012
1	ArylsulfatasesIBA 10/2010
1	Messenger RNA (mRNA)IBA 10/2009
1	OligonucleotidesIBA 07/2006
1	Sodium Channels (Sodium Channel)IBA 07/2006
1	polyglutamineIBA 05/2005
1	NeuropeptidesIBA 05/2005
1	Apoptosis Regulatory ProteinsIBA 10/2003
1	Phosphotransferases (Kinase)IBA 10/2003
1	Protein Kinase CIBA 10/2003
1	Protein Isoforms (Isoforms)IBA 10/2003

Therapy/Procedure

1	Intranasal Administration 01/2024